Market Cap (In USD)
168.04 Million
Revenue (In USD)
-
Net Income (In USD)
-67.32 Thousand
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0411-0.05
- PE
- -
- EPS
- -
- Beta Value
- -1.029
- ISIN
- US88165K1198
- CUSIP
- -
- CIK
- 1860871
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Ryan H. Saadi M.D., M.P.H, M.P.H.
- Employee Count
- -
- Website
- https://tevogen.com
- Ipo Date
- Details
- Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.
More Stocks
-
AAATECHAAA Technologies Limited
AAATECH
-
SM
-
LMNRLimoneira Company
LMNR
-
9273
-
GRCGF
-
CARBORUNIVCarborundum Universal Limited
CARBORUNIV
-
MOVEMovano Inc.
MOVE
-
6931